Translate
Sangamo Therapeutics Inc
About
Sangamo Therapeutics Inc (NASDAQ:SGMO) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market
Mar 30 2026
Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results
Mar 19 2026
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call
Mar 9 2026
Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease
Feb 3 2026
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at WORLDSymposium™ 2026
Recent Videos
Sangamo's Game-Changing Gene Therapy for Fabry Disease! #GeneTherapy #FabryDisease #Biotechnology
Apr 07, 2026
Comprar acciones de Sangamo Therapeutics Inc: guía rápida (SGMO)
Apr 03, 2026
A Biotech s Fight for Survival
Mar 31, 2026
Is Sangamo Therapeutics (SGMO) the Ultimate Penny Stock Comeback? SGMO STOCK PODCAST TODAY ANALYSIS
Mar 10, 2026
Financials
Revenue
$39.55 M
Market Cap
$124.32 M
EPS
-0.44